Ditchcarbon
  • Customers
  1. Organizations
  2. Alvotech
Public Profile
Pharmaceutical Preparation Manufacturing
LU
updated 9 days ago

Alvotech

Company website

Alvotech, officially known as Alvotech Holdings SA, is a prominent biopharmaceutical company headquartered in Luxembourg (LU). Founded in 2013, Alvotech focuses on the development and manufacturing of high-quality biosimilars, addressing the growing demand for affordable biologic therapies. With a strong operational presence in Europe and North America, the company has established itself as a key player in the biosimilars market. Alvotech's core offerings include a diverse portfolio of biosimilar products that are distinguished by their rigorous development processes and commitment to quality. The company has achieved significant milestones, including successful regulatory approvals and partnerships that enhance its market position. Recognised for its innovative approach, Alvotech continues to lead in the biopharmaceutical industry, striving to improve patient access to essential therapies.

DitchCarbon Score

How does Alvotech's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

46

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

28

Industry Benchmark

Alvotech's score of 46 is higher than 68% of the industry. This can give you a sense of how well the company is doing compared to its peers.

68%

Let us know if this data was useful to you

Alvotech's reported carbon emissions

In 2024, Alvotech reported total carbon emissions of approximately 923,000 kg CO2e, with emissions distributed across various scopes. Specifically, Scope 1 emissions were about 39,800 kg CO2e, including 25,500 kg CO2e from fugitive emissions. Scope 2 emissions totalled approximately 231,000 kg CO2e, primarily from purchased electricity, which accounted for about 205,000 kg CO2e. The most significant contributor to their carbon footprint was Scope 3 emissions, which reached approximately 574,000 kg CO2e, with business travel alone contributing about 386,000 kg CO2e. In 2023, Alvotech's total emissions were reported at approximately 923,000 kg CO2e, with Scope 1 emissions at about 20,000 kg CO2e and Scope 2 emissions at approximately 209,000 kg CO2e. Scope 3 emissions for that year were around 555,000 kg CO2e. Alvotech has not set specific reduction targets or initiatives as part of their climate commitments, and there are no documented climate pledges or SBTi targets. The emissions data is not cascaded from any parent organisation, indicating that Alvotech independently reports its emissions and climate performance. Overall, Alvotech's emissions profile highlights the need for ongoing assessment and potential strategies to mitigate their carbon footprint, particularly in Scope 3 emissions, which represent the largest share of their total emissions.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

20202021202220232024
Scope 1
16,000
00,000
00,000
00,000
00,000
Scope 2
202,000
000,000
000,000
000,000
000,000
Scope 3
261,000
000,000
000,000
000,000
000,000

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Alvotech's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Alvotech is in LU, which has a very low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Alvotech is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Formycon AG

DE
•
Pharmaceutical Preparation Manufacturing
Updated 14 days ago

Abbvie

US
•
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

Mabxience S.A.

CH
•
Pharmaceutical Preparation Manufacturing
Updated 9 days ago

Amgen

US
•
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

Sandoz International GmbH

DE
•
Pharmaceutical Preparation Manufacturing
Updated 14 days ago

Xbrane Biopharma AB

SE
•
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v250808.1
enquiries@ditchcarbon.com+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
Verified byUL Verified
Partnered withCDP
ProductPortalDataDocumentationIntegrationsChangelogPricing
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesMethodologyBlogFAQOrganizationsIndustriesSBTI APITrust Centre
AboutTeamCareersLicense AgreementPrivacy